Skip to main content
← Back to Science Explained

Access and sourcing

Understand the system around the molecule

Price, access, shortages, telehealth models, brands, compounds, and sources are connected. This series reads the market as a system instead of a pile of offers.

Market lenses

01Price pressure
02Access changes
03Source claims

Read the peptide market

  1. 01Why Prices Vary So Much in PeptidesPeptide prices look irrational until you see what each price actually includes — synthesis, purity, testing, documentation, and the layers between production and you.
  2. 02What "Same Compound" Actually Means Across SourcesThe compound name points to an intended molecule — it says nothing about how it was made, purified, or tested, which is where real differences live.
  3. 03How Shortages Change Access OvernightShortage-based compounding access is a temporary regulatory pathway tied to FDA's drug shortages list — when that status changes, access can change with it.
  4. 04Why Telehealth Models CollapseTelehealth reduced friction and made GLP-1 access feel modern — but models built for rapid expansion become exposed when pricing, supply, and regulatory conditions change.
  5. 05The Difference Between Brand, Compound, and SourceBrand, compound, and source are three distinct layers that each answer a different question — collapsing them into one is where market confusion starts.